The pro-inflammatory cytokine IL-36γ was known before to be critically involved in several inflammatory disorders such as psoriasis (29, 44, 45), inflammatory bowel disease (23, 32, 44), rheumatoid arthritis (21), or systemic lupus erythematosus (SLE) (24). Here, IL36G is linked to inflammatory bowel disease.